SEC Filings

Filing date	Form	Description	View
06/05/18	CT ORDER	CT ORDER	View HTML 9999999997-18-006163.pdf
12/20/18	CT ORDER	CT ORDER	View HTML 9999999997-18-009627.pdf
08/09/19	CT ORDER	CT ORDER	View HTML 9999999997-19-006419.pdf
03/17/15	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	View HTML 0001047469-15-002361.pdf 0001047469-15-002361.rtf 0001047469-15-002361.xls
03/25/16	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	View HTML 0001047469-16-011603.pdf 0001047469-16-011603.rtf 0001047469-16-011603.xls
04/11/17	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	View HTML 0001047469-17-002506.pdf 0001047469-17-002506.rtf 0001047469-17-002506.xls
03/21/18	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	View HTML Theravance Biopharma, Inc. Proxy Statement.pdf 315.4 KB 0001047469-18-001961.rtf 0001047469-18-001961.xls
03/20/19	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	View HTML 0001047469-19-001474.pdf 0001047469-19-001474.rtf 0001047469-19-001474.xls
03/24/20	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	View HTML 0001047469-20-001736.pdf 0001047469-20-001736.rtf 0001047469-20-001736.xls
03/22/21	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	View HTML 0001104659-21-039784.pdf 0001104659-21-039784.rtf 0001104659-21-039784.xls

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.